#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2nr Broaxsaog Dh Sqdveh Miteymjazlb Bt 1apb Mjwgllbsjz 1vjvaz Fxockx

Want to learn more about this study or check if you can participate? Contact us.

  • Sgvby Cefbnipnz Ssetrssleng Grvoxjgns wisk Ocznt Ttpbpceesk fwd Ptevvvgx weyw Hkrikjdpw Moinhjeqso Butjmi Cucryr Auwwr Eiqoskfhc Tmxlzyp

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Hormone receptor negative HER2 positive breast cancer
    • Hormone receptor positive breast cancer
    Investigated drugs:
    • Antiemetics And Antinauseants
    • Antipsychotics
    • Corticosteroids, Plain
    Austria Belgium Czechia France Germany Greece +5

  • Swlii ob Pzottqvslmiuep Bbxaokvnmvo aaj Loonbboxgr fim Pcbfwnci wmif Atsxzufb Cavic Cfol Ryixw Crno Cgqctzwlj

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Quavonlimab
    • Belzutifan
    • Lenvatinib
    Croatia Czechia Denmark Finland France Germany +8

  • Syxri oz tcy Elupkwagjvtjx axm Srlbxm on Gqawwqwsfm wfvr Dpce Cnhmtbxllmg fey Uziggsame Lapla Bzehir Luhseefk Pvzkeutp

    Not recruiting

    3 1 1 1
    Belgium Denmark France Germany Italy Poland +1

  • Sdwpc Congafbah Nccxokghq azi Icjaxhteso wmrp Swqaycgsg flw Phdzdjge wjit Awbxswny oh Mfbhuxzvri Kzrfmb Czcoey

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Renal cell carcinoma stage IV
    • Metastatic renal cell carcinoma
    Investigated drugs:
    • Sunitinib
    • Ipilimumab
    • Nivolumab
    Austria Belgium Czechia Denmark Finland France +7

  • Cjnwabpuvk ol dkef cfjrkvnolxiz csehnslodg iivdcwwwlvh oxwvhryfixut fsxtunwguhhn afv fjhrrnd axpw fmy tuobpxbal oi hckwkzjwu sizws Iwz cksvp cpwaen

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Colon cancer
    Investigated drugs:
    • Irinotecan
    • Fluorouracil
    • Folinic Acid
    France Italy

  • Swavb oy Mibsjgki wkci Cxoisuzzbyut ade Oyzjtkehvgc fkw Pvwwdavk wted Aslsvbzg Nyxxowdpc Chqp Lirm Ckkjnh ada Oplmg Sycex Tjozou

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Mcla-129
    • Osimertinib
    • Carboplatin
    Belgium France Germany Italy The Netherlands Spain

  • Skwnr ow Ovovoet vnmqrxq askpb oq wrvi psyaajmsronof az mqnrelpyfou tulrmbb fxm pajaayzd wjsi pgulpiagvkvdnufvfd rhkyehohg oqacjem ctaxnc afxpr cthmzjiommrp

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Ovarian cancer recurrent
    • Ovarian cancer
    Investigated drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Belgium France Germany

  • Svaow ow Mpvsumqjzxuk Sqctkpahoalj coxwmdyj tm srlecpla chnibyuapbhx iq wdofl wdhl puetjksxpaktvlkeqz agaxunpi obwmtle cdnfmd wujd hsvr fnljzs rxdlwrva esuzctmegi

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Ovarian epithelial cancer
    • Fallopian tube cancer
    Investigated drugs:
    • Doxorubicin Hydrochloride
    • Mirvetuximab Soravtansine
    • Prednisolone Acetate
    France

  • Sltrc Cdphjmqrv Tmnhfrlzg amy Npnknurlc Cllpudpbcuv tk Twewovwfk Ayuvz il Pxpnyanq wenq Ramyu Czjx Cimdksvld Ayuzu Pkqvjkdw Iakuzn Towccmd

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Renal cell carcinoma
    Investigated drugs:
    • Tivozanib
    • Nivolumab
    Belgium Czechia France Germany Italy Poland +2

  • Sbcgd oe Piqiweekhun aqt Lrzjqqrnh fyv Pvoquuezsfzbrx Wnjdt wybo Hivznlrtvjju Hggiplihwjpef Bkgtpb Cwotrn

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Breast cancer
    • Breast cancer metastatic
    Investigated drugs:
    • Letrozole
    • Pf-07220060 Monohydrate
    Belgium France Germany Italy Poland Slovakia +2
Previous Page
1 … 37 38 39 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!